Cargando…
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease
BACKGROUND: Phosphorylcholine is one of the major epitopes of oxidised low density lipoprotein. Low levels of IgM antibodies against phosphorylcholine (anti-PC) are associated with development of myocardial infarction and stroke. It has been shown that patients with Alzheimer’s disease and other dem...
Autores principales: | Silajdžić, Edina, Björkqvist, Maria, Hansson, Oskar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324431/ https://www.ncbi.nlm.nih.gov/pubmed/25651913 http://dx.doi.org/10.1186/s12883-015-0260-1 |
Ejemplares similares
-
No Diagnostic Value of Plasma Clusterin in Alzheimer's Disease
por: Silajdžić, Edina, et al.
Publicado: (2012) -
A Critical Evaluation of Wet Biomarkers for Huntington’s Disease: Current Status and Ways Forward
por: Silajdžić, Edina, et al.
Publicado: (2018) -
Evaluation of a Previously Suggested Plasma Biomarker Panel to Identify Alzheimer's Disease
por: Björkqvist, Maria, et al.
Publicado: (2012) -
Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease
por: Stomrud, Erik, et al.
Publicado: (2010) -
Antibodies against Phosphorylcholine—Implications for Chronic Inflammatory Diseases
por: Frostegård, Johan
Publicado: (2023)